246 related articles for article (PubMed ID: 18201436)
1. Cytokine expression in peripheral blood lymphocytes before and after aspirin desensitization in aspirin-exacerbated respiratory disease.
Shome GP; Tarbox J; Shearer M; Kennedy R
Allergy Asthma Proc; 2007; 28(6):706-10. PubMed ID: 18201436
[TBL] [Abstract][Full Text] [Related]
2. Effect of aspirin desensitization on T-cell cytokines and plasma lipoxins in aspirin-exacerbated respiratory disease.
Aksu K; Kurt E; Alatas Ö; Gülbas Z
Allergy Asthma Proc; 2014; 35(2):148-55. PubMed ID: 24717792
[TBL] [Abstract][Full Text] [Related]
3. Cytokine expression before and after aspirin desensitization therapy in aspirin-exacerbated respiratory disease.
Aktas A; Kurt E; Gulbas Z
Inflammation; 2013 Dec; 36(6):1553-9. PubMed ID: 23912646
[TBL] [Abstract][Full Text] [Related]
4. The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data.
San Nicoló M; Högerle C; Gellrich D; Eder K; Pfrogner E; Gröger M
Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):445-452. PubMed ID: 31655881
[TBL] [Abstract][Full Text] [Related]
5. The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD).
Spies JW; Valera FC; Cordeiro DL; de Mendonça TN; Leite MG; Tamashiro E; Arruda LK; Anselmo-Lima WT
Braz J Otorhinolaryngol; 2016; 82(3):263-8. PubMed ID: 26601997
[TBL] [Abstract][Full Text] [Related]
6. Aspirin desensitization for chronic hyperplastic sinusitis, nasal polyposis, and asthma triad.
Mardiney M; Borish L
Arch Otolaryngol Head Neck Surg; 2001 Oct; 127(10):1287. PubMed ID: 11587618
[No Abstract] [Full Text] [Related]
7. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
[TBL] [Abstract][Full Text] [Related]
8. Role of aspirin desensitization in the management of chronic rhinosinusitis.
Rizk H
Curr Opin Otolaryngol Head Neck Surg; 2011 Jun; 19(3):210-7. PubMed ID: 21372715
[TBL] [Abstract][Full Text] [Related]
9. Does it make sense to "desens"? Aspirin desensitization in the treatment of chronic rhinosinusitis.
Lee JY; Simon RA
Curr Allergy Asthma Rep; 2006 May; 6(3):183-4. PubMed ID: 16579867
[No Abstract] [Full Text] [Related]
10. Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)?
Klimek L; Dollner R; Pfaar O; Mullol J
Curr Allergy Asthma Rep; 2014 Jun; 14(6):441. PubMed ID: 24682773
[TBL] [Abstract][Full Text] [Related]
11. Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial.
Esmaeilzadeh H; Nabavi M; Aryan Z; Arshi S; Bemanian MH; Fallahpour M; Mortazavi N
Clin Immunol; 2015 Oct; 160(2):349-57. PubMed ID: 26083948
[TBL] [Abstract][Full Text] [Related]
12. A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.
DeGregorio GA; Singer J; Cahill KN; Laidlaw T
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1174-1180. PubMed ID: 30391549
[TBL] [Abstract][Full Text] [Related]
13. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.
Świerczyńska-Krępa M; Sanak M; Bochenek G; Stręk P; Ćmiel A; Gielicz A; Plutecka H; Szczeklik A; Niżankowska-Mogilnicka E
J Allergy Clin Immunol; 2014 Oct; 134(4):883-90. PubMed ID: 24767875
[TBL] [Abstract][Full Text] [Related]
14. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
Simon RA; Dazy KM; Waldram JD
Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
[TBL] [Abstract][Full Text] [Related]
15. [Self-desensitization with aspirin in a patient with aspirin intolerance].
Rozsasi A; Keck T
Laryngorhinootologie; 2009 Aug; 88(8):540-1. PubMed ID: 19562656
[No Abstract] [Full Text] [Related]
16. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
Ledford DK; Wenzel SE; Lockey RF
J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
[TBL] [Abstract][Full Text] [Related]
17. Aspirin-exacerbated respiratory disease and current treatment modalities.
Sakalar EG; Muluk NB; Kar M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
[TBL] [Abstract][Full Text] [Related]
18. An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated Respiratory Disease.
Chen JR; Buchmiller BL; Khan DA
J Allergy Clin Immunol Pract; 2015; 3(6):926-31.e1. PubMed ID: 26282158
[TBL] [Abstract][Full Text] [Related]
19. Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine.
Makowska JS; Olszewska-Ziąber A; Bieńkiewicz B; Lewandowska-Polak A; Kurowski M; Woźniakowski B; Rotkiewicz A; Kowalski ML
Allergy Asthma Proc; 2016 May; 37(3):216-24. PubMed ID: 27178890
[TBL] [Abstract][Full Text] [Related]
20. Increased level of interleukin-13, but not interleukin-4 and interferon-γ in chronic rhinosinusitis with nasal polyps.
Nabavi M; Arshi S; Bahrami A; Aryan Z; Bemanian MH; Esmaeilzadeh H; Jalali F; Pousti SB; Rezaei N
Allergol Immunopathol (Madr); 2014; 42(5):465-71. PubMed ID: 23969075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]